CUBE vs TBPH · P/E 25, rev $1.07B vs P/E 7.5, rev $18.8M
CubeSmart (CUBE) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported TBPH revenue for 2024-12-31 was $18.8M. Net income was -$15.5M. Revenue was up 11.2% from 2024-09-30 to 2024-12-31. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the CUBE and TBPH stock pages for the full models.
Not investment advice.